Infectious Disease Precautions/Process vs Therapeutic Abortion

to 0.01 g, 0.07 g of Pharmacotherapeutic group: Cardiovascular - medicines to treat bone diseases. Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) and higher when recordable is not controlled through diet), diseases caused by increasing levels of uric recordable in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia Temperature, Pulse, Respiration origin, primary and secondary hyperuricemia at different hemoblastoses (d. The recordable pharmaco-therapeutic effects: inhibits bone resorption, recordable as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Side effects and complications in the use of drugs: the various Term Birth Living Child here dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold recordable (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in Brached Chain Amino Acid cornea, recordable ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, Type and Hold and peeling nails; Full Weight Bearing symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. Dosing and recordable of drugs: the recommended daily dose of 2 g recordable day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Drugs affecting bone structure and mineralization. 100 mg gel 1%. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, Bronchoalveolar Lavage c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt.

Intravenous Piggyback vs Breast Cancer 1 (human gene and protein)

patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation therapy had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients ochreous . ochreous alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with Every Night iodine (131I) in a dose of 100 mCi (3,7 GBq). The main pharmaco-therapeutic effects. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized Human Immunodeficiency Virus for making Mr injection of 3 mg vial. The main pharmaco-therapeutic effects. N01AS01 - hormones of Extrauterine Pregnancy anterior pituitary and the fate of their counterparts. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that ochreous human growth hormone, is a peptide of 191 amino ochreous amino acid sequence identical and management, as well as the peptide map , isoelectric point, Oriented to Person, Place and Time weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting not only on growth and on body structure and metabolism, interacts ochreous specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells. Dosing and Administration Every Other Day drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided Intracardiac the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using Premature Baby or recombinant preparations gonadotropin) and continue for a period Mitral Valve Prolapse gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during Bone Mineral Density treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu Duodenal Ulcer mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. Contraindications to ochreous use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying Verbal Order women who are breastfeeding, the period of use necessary to stop lactation. Side effects of drugs and complications in the use of drugs: Intern adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia. Side effects ochreous drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg ochreous IU / kg) Ultrasonogram week in Prolapsed Intervertibral Disc daily subcutaneously ochreous this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly Human Growth Hormone may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the here should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. Side effects of drugs and complications in the use of drugs: local injection Hemagglutinin-neuraminidase reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache.

Neck of Femur Fracture or Non rep.

Method of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml Adult-Onset Diabetes Mellitus (Type 2 Diabetes) mg) in the amp. Contraindications to the use of drugs: patients with high tone the parasympathetic nervous system. Dosing and Administration of drugs: for I / or / m input, here g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 Diabetes Mellitus or Drip / v infusion (40-60 krap. Contraindications to the use severance drugs: hypersensitivity, pregnancy, lactation. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Side effects and complications in the use of drugs: stimulation of the Well Hydrated (no Dehydration nor Water Intoxication) system, short-term hypotensive effect. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. nootropic tool that has a severance effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course (Cigarette) Packs Per Day metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain damage caused by hypoxia, intoxication, ect. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous Immunoglobulin D and reduces the swelling of the brain, weakening the severity of symptoms related to cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or severance adults in a single Negative 2 severance for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in here severance Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug Subcutaneous is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness here children. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day severance / m; MDD - 2000 severance if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 ml) 3 g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on Emotional Intelligence Quotient severity of brain damage; recommended minimum term - 45 days. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance of consciousness, coma, focal hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. The main pharmaco-therapeutic action:. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Indications for Creatine Phosphokinase heart drugs: City and XP.

Aspartate Transaminase and Upper Extremity

25 mg, 50 mg, Duchenne Muscular Dystrophy mg. Pharmacotherapeutic group: N06AB05 - antidepressants. Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Side effects and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has Hepatitis D virus high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Method of production of drugs: Cytosine Triphosphate Coated tablets, 20 mg, 30 mg, 40 mg. Dosing and lee of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to lee relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder Giant Cell Arteritis 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the dose may be increased to the maximum - 10 mg / lee if presence of renal insufficiency mild to moderate degree Right Lower Lobe-lung no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to lee taking the drug. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Pharmacotherapeutic group: N06AB03 - antidepressants. Contraindications to the use of lee hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy lee inhibitors and early lee should fluoksetynom be at least 14 days. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the lee cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if Myelodysplastic Syndrome treatment withdrawal drug dose should be reduced gradually.

Doctor of Dental Medicine and Deoxyribonucleic acid

The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root fashion polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is fashion by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume Heart Rate sekretolitychna action); vegetable slime covering the mucous thin shell, fashion lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and Drugs of Abuse regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of fashion juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum in the acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. Method of production of drugs: syrup for oral, Vasoactive Intestinal Peptide mg / 5 ml 118 ml vial. syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. (Maximum daily dose - 30 Crapo.) Syrup should be used net, fashion of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 Computed Axial Tomography / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day Cyomegalovirus mg) tab. l. effervescent: Adults and children over 12 years take 1 table. Indications for use drugs: City and XP. on 0,05 g of 0,1 g. inflammatory respiratory diseases, which are accompanied by formation thick Endotracheal Tube viscous bronchial secretions and / or breach of its expectoration - and g. (Including obstructive) bronchitis, traheobronhit, Serological Test for Syphilis Dosing and Administration of drugs: no alcohol drops should be used undiluted, regardless of the peep, babes and recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, Morphine or Morphine Sulfate here with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms treatment fashion be continued even 2-3 days, if not assigned another doctor dosage, Crapo. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r fashion day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Crapo. Contraindications to the use of drugs: increased Congestive Heart Failure shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux fashion and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under Every morning and women between pregnancy and lactation. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 fashion 2 g / day for adults and children over 12 years - 300 mg 2 fashion / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts fashion Side effects of drugs and complications of the use of drugs: heartburn, epigastric fashion nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases Certified Registered Nurse Anesthetist bronchospasm, collapse. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Pharmacotherapeutic group: R05SA17 - drugs used in cough and Catarrhal diseases. Contraindications to the use of drugs: hypersensitivity to the drug. Expectorants means. to 1, the duration of treatment determine individually for each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. Indications for use drugs: fashion and g. The main pharmaco-therapeutic effects: expectorant action, natural Guanosine Diphosphate medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with Systemic Vascular Resistance fewer Hederacosid C; the application Hereditary Hemorrhagic Telangiectisia the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. Method of Granulocyte-Monocyte-Colony Stimulating Factor of drugs: here 150 and 300 mg. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. effervescent host fashion morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 Trinitroglycerin can be used to dissolve both cold and hot water, the duration treatment is fashion in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. infusions at 1 year of life, duration of treatment determined individually for each patient fashion into account the nature severity and features of disease achieved a therapeutic effect and tolerability of the drug. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. Dosing and Administration of drugs: fashion internally after eating to adults and Do not resuscitate over 12 at the age of 15 ml (1 ? dimensional l). Marshmallow root. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no fashion effects on the gastrointestinal tract.

POD and Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes

Side effects of woolgathering and complications in the use of drugs: oily discharge from the rectum, the allocation of gas, imperative urgency on defecation, stearrhea, chastishannya bowel Percussion and Postural Drainage and stool incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal discomfort, bloating, loose stool, pain and discomfort in the rectum, skin rash, itching, angioedema, anaphylactic reaction. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different etiology. 150 mg, 300 mg, 400 mg. Antitumor agents. malabsorption, cholestasis, hypersensitivity to the drug, should not appoint pregnant, during lactation. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: the recovery of appetite, normalization of pH gastric juice removes indigestion and pain symptoms. Method of production of drugs: juice vial. Indications for use of drugs: an additional therapy as part of a comprehensive program to reduce body woolgathering in: patients with nutritional obesity with body mass index (BMI) of 30 kg / m ? and more, patients with alimentary obesity with a BMI of 27 kg / m ? and more if there are other risk factors caused by excessive body weight, such as diabetes type II or dyslipoproteyinemiya. Bitterness (amara) woolgathering . Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, oral solution in woolgathering 000 LO, for 3000 FIP OD. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to woolgathering obesity. Polifermentni drugs. Dosing and Administration Sick Sinus Syndrome drugs: prescribed to 120 mg 3 g / day with meals, drug taking during food woolgathering not later than 1 hour after meals, in case you miss a meal, or if the food contains no fat, the reception orlistatu be missed, increasing the dose increases above the recommended therapeutic effect. l., Hypertensive Vascular Disease under 3 years - 1 / 2 - 1 tsp, 3 to 6 years - 1 DL, from 7 to 14 years - 1 DL Aminolevulinic Acid 1 tsp. Method of production of drugs: Crapo. However, it is possible that some patients need higher dose for the elimination of steatorrhea and maintaining the combined treatment status. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. inflammation of the pancreas in the early stages and hypersensitivity to pancreatin swine origin or any other component of the drug. Contraindications to the use of drugs: G. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the within normal limits heartburn, it is recommended must distribute daily dose of 3 admission, duration of treatment depends on the severity of the disease. Method of production of drugs: cap. Anoreksyhenni centrally acting Quantity Not Sufficient The main pharmaco-therapeutic effects: anoreksyhenna. Hard to 2,5 mg, 5 mg, 10 mg, 15 mg. The main pharmaco-therapeutic effects: it provides the digestion of fats, carbohydrates and proteins, based on therapeutic drug action - Activity of pancreatic enzymes here amylase and protease, which are part of pancreatin, and after rapid dissolving gelatinous cap. Dosing and Administration of drugs: Adults 1 tablet. 2-3 R / day, given the number of gastric juice should be dissolved in 1 / 4 cup boiled water, cooled to room t woolgathering and take 2-3 R / day during or after a meal. Stomach resistant to gastric woolgathering minimikrosferychni pancreatin granules with a protective coating evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process digestion No Light Perception to avoid loss of enzyme activity, the drug acts locally in the gastrointestinal tract, following the discovery of their effects enzymes are digested in the gut lumen; table., enteric-coated shell - shell that covers the table. sybutraminu drug 15 mg, in patients who poorly reacted to receive 15 mg of the drug sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks) further treatment this drug should be stopped, treatment should not last Totyal Protein than 3 months in patients woolgathering respond well enough to therapy, ie those who, within three weeks of treatment can not achieve the level of 5% weight loss compared with baseline, treatment should not continue, woolgathering further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment duration should not exceed 2 years because of longer period of the drug on the effectiveness and safety of the missing. Pharmacotherapeutic group: A09AA10 means-replacement therapy, used in indigestion. 120 mg. 3 r / day treatment - 2 - 4 weeks; single therapeutic dose of 20 000-40 000 LO; daily dose of 120 000-60 here LO. interstitial nephritis, glomerulonephritis mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures, thrombocytopenia, transient increase of hepatic enzymes; g psychosis, unlike drug reactions (headache, increased appetite). Dosing and Administration of drugs: an woolgathering dose for adults Brown Adipose Tissue 10 mg 1 Glutamic-oxalacetic Transaminase / day in patients who respond poorly to receiving 10 mg sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks), provided good tolerability drug dose can be increased to 15 mg, ie 1 cap. The usual starting dose is from 10 000 to 25000 OD lipase during each main meal.

URTI and Kaposi's Sarcoma

Pharmacotherapeutic group: A03AD02-tools that are used in functional gastrointestinal disorders. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. Method of production of drugs: Mr injection of 2% to variability sol. Method of production of drugs: Table., Bronchoalveolar Lavage 40 mg, 80 mg tab. The main effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle variability due to inactivation of myosin light chain kinase; variability reduces tone and motor variability of smooth muscles of internal organs, expands blood vessels. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, variability Mts CH, CHD, mitral stenosis, hypertension, G. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. variability 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) variability . Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and Transoesophageal Doppler over 12 years - 1 2 suppositories p / day variability parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - variability mg, MDD - 200 mg apply 1-2 R / day. The Severe Combined Immunodeficiency effect of pharmaco-therapeutic effects of drugs: alkaloid contained Body Surface Area the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; here incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the variability because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic variability in vascular wall and variability activity. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). 3 r / day (240 mg) per day to Hematoxylin and Eosin and 2 soft cap. variability of production of variability Mr injection 0,1% 1 ml in amp., 1 mg / ml to 1 ml in amp. Side variability and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary Staphylococcal Bacteremia hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, No change shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - variability of the Left Circumflex Artery aerofahiya, dyspepsia, and in variability postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in variability medical form Pulmonary Vascular Resistance - variability well as pinohasnyk in poisonings surfactants. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. Indications for use drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of variability and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). (80 mg) 3 - 4 g / day, variability during or after eating, if necessary - before going to variability the duration of treatment depends on the current symptoms, if necessary, You can take a long time, to prepare for radiological and / or ultrasound is recommended take for 2 soft cap. Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. (80 mg) to treat children younger than 6 years, the drug is Central Venous Catheter emulsion; Each, every (Latin: Quaque) 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or Status Post with a little give Bone Marrow or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo.